Major reshuffle at drug controller's office

Nine officials transferred recently; DCGI says move to bring transparency, accountability into the system

Sushmi Dey New Delhi
Last Updated : Feb 01 2014 | 1:48 AM IST
At a time when the Indian drug regulator is under a spotlight following international scrutiny of domestic pharmaceutical companies, the government has ordered transfers in the Central Drug Standard Control Organisation (CDSCO), the office of the drugs controller general of India (DCGI).

As many as nine transfer orders were issued earlier this week, of which five are related to top officials in the CDSCO. While four deputy drug controllers (DDC) are transferred from this headquarter to different zonal offices, one DDC with additional charge of west zone is being brought back to the New Delhi headquarters. The transfer order, issued on January 27, has been reviewed by Business Standard.

Sources suggest the move comes in the wake of a recent corruption case in Hyderabad where a DDC was allegedly found accepting a bribe from a blood bank. However, DCGI G N Singh said the transfers are “isolated from any such case”. “We want to bring transparency and accountability into the system. We realised that the position of deputy drug controller is very sensitive and they need rotation, which will also give them more exposure,” Singh said.

The move assumes significance because of the events presently surrounding the drug manufacturing industry. As CDSCO has been in the spotlight for its lack of resources, inadequate monitoring of clinical trials and approval of new drugs, of late it has also been criticised for its failure to monitor drug manufacturing practices effectively.

The latest to come under the scanner is Ranbaxy Laboratories, whose India manufactured drugs are barred from the US. While DCGI has ordered inspection of the company’s Toansa facility, files related to various show-cause notices served to Ranbaxy and others were being handled by DDCs so far.

The four DDCs to be moved from the CDSCO headquarter are K Bangarurajan, A K Pradhan, S P Shani and S E Reddy.

Singh said such rotations would now be conducted every three years on an average.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 01 2014 | 12:35 AM IST

Next Story